Clinical trial
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
NCT04089059 · Endotronix, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT04089059 |
|---|---|
| Title | PROACTIVE-HF IDE Trial Heart Failure NYHA Class III |
| Official title | A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial) |
| Acronym | PROACTIVE-HF |
| Lead sponsor | Endotronix, Inc., Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Heart Failure NYHA Class III |
| Intervention type | Device |
| Interventions | Cordella™ Pulmonary Artery Sensor System |
| Enrollment | 738 |
| Start date | Jan 10, 2020 |
| Primary completion | Apr 1, 2028 |
| Completion | Apr 1, 2028 |
| First posted | Sep 13, 2019 |
| Last update posted | Mar 3, 2025 |
| Countries | Belgium, Ireland, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: